Trump Claims He's Defending U.S. Companies — But Businesses Disagree


By David Williams

This summer, President Trump imposed a 25-percent tariff on $34 billion of Chinese goods. The move follows his June levies on steel and aluminum from Canada, Mexico, and Europe.

President Trump sincerely believes these tariffs will bolster American businesses. His administration has argued that taxing imports will create a "level playing field" for U.S. firms, which have been subjected to "Trade Abuse for many decades."

Yet American firms almost unanimously oppose the tariffs. They understand that import taxes will harm workers and consumers. If the president truly wants to help U.S. firms, he should listen to them -- and call off the trade war.

For months, businesses have warned that tariffs will clobber American workers. The administration has largely dismissed these concerns. Commerce Secretary Wilbur Ross shrugged off the warnings as "hyperbole," adding that "I don't think there's really a lot for anybody to complain about."

Sec. Ross should tell that to the 60 workers who just lost their jobs at America's largest nail manufacturer. After the administration's steel tariffs went into effect, Mid Continent Nail Company was forced to hike prices on its steel nails by 20 percent. Half its customers defected to cheaper sellers. The collapse in orders compelled the firm to lay off 60 employees. The company, in self-described "crisis mode," is weighing an additional 200 layoffs.

The president's tariffs aren't just impacting companies that use large amounts of steel. They're wreaking havoc even in unrelated industries. American exporters worry that foreign nations' retaliatory tariffs will cripple their own businesses.

Consider powerboat manufacturer Correct Craft. The company is reconsidering its expansion plans due to fears of a prolonged trade war -- Mexico, Canada, and the EU have already threatened to impose tariffs on American boats.

The energy industry also faces enormous risks. America's oil and gas producers, which support 10.3 million American jobs, will likely have to scale back production and lay off workers due to the president's tariffs. By making steel more expensive, the tariffs will increase the cost of a typical pipeline project by $76 million, according to a study conducted by consulting firm ICF. Beijing has also promised to impose tariffs on imported American oil and natural gas -- meaning the largest foreign buyer of U.S. crude may soon turn elsewhere for its fuel needs. U.S. energy companies may be forced to resell up to 400,000 barrels a day of oil at a discounted rate. The vice president of one Texas drilling company warns the tariffs will hobble the oil and gas industry, which accounts for up to 8 percent of the U.S. economy. "It is going to hurt everyone for the short term," he recently told Reuters.

Ordinary voters from across the political spectrum believe the tariffs will hurt the U.S. economy. Nearly, six in ten Americans say that the trade hostilities will leave them personally worse off, according to a new CBS News poll. One analysis estimates that President Trump's tariffs on Chinese goods alone are equivalent to a $12.5 billion tax on U.S. consumers.

President Trump no doubt truly wants to help American businesses. But raising their cost of goods and angering trading partners isn't the way to do it. Business leaders and everyday workers can only hope the administration calls off its misguided trade war.

David Williams is President of the Taxpayers Protection Alliance. This piece originally ran in the Detroit News.

More Resources


05/01/2024
A Bystander to '60s Protests, Biden Now Becomes a Target
When students took over Hamilton Hall at Columbia University in April 1968, a young Joe Biden was studying law 250

more info


05/01/2024
Campus Goes Crazy, Democrats Hardest Hit
Some people are their own worst enemy - unable to get out of their own way, derailing their own good opportunities, large or small. You know the type - late to the interview for the dream job, says something stupid when meeting someone they're attracted to, or just generally doing or saying the wrong thing at the wrong moment.

more info


05/01/2024
Why Trump's New Campaign Strategy Is So Scary
This is a completely different strategy than we're used to.

more info


05/01/2024
Biden Atop the Greasy Pole
The Democratic Party is changing under President Joe Biden, but not at his direction.

more info


05/01/2024
How To Get More Young People To Vote
Twenty years ago, I published "Taking Back the Vote: Getting American Youth Involved in Our Democracy." The book grew out of a personal passion: Once my oldest child was able to cast a ballot, I became fascinated with the potential of our youngest voters to shape politics. Yet American youths face unique obstacles at the ballot box.

more info


05/01/2024
Dems Use Taxpayer Dollars To Target Young Voters
Democrat officials in AZ and NV are using taxpayer dollars to register and turn out Dem-favorable young voters ahead of the 2024 election.

more info


05/01/2024
GOP Senators a Bigger Threat to Constitution Than Trump
Donald Trump may talk about wanting to act as "a dictator" if he wins a second term. But what Trump really wants is to be a king.

more info


05/01/2024
Ukraine Funding Helps Prolong Bloody Stalemate
RCP reporter Philip Wegmann interviewed Wisconsin Republican Sen. Ron Johnson, a member of the Foreign Relations Committee, about why he opposed the latest round of U.S. funding for the Ukraine War, on Tuesday's edition of the RealClearPolitics radio show (Monday through Friday on SiriusX's POTUS Channel 124).

more info


05/01/2024
Women of Trump's GOP Try To Show Who Is Most Macho
To be as tough as the guys, Republicans Kristi Noem shot her dog, Joni Ernst castrated hogs, Sarah Palin advocated shooting wolves from the air.

more info


05/01/2024
Biden's Title IX Rewrite Puts Women and Girls at Risk
The Biden ED finalized its overhaul of Title IX, the landmark 1972 law establishing important protections against sex-based discrimination.

more info


05/01/2024
The Lie of the Century: The Origin of COVID-19
Four years after the outbreak of the COVID-19 pandemic in the Chinese city of Wuhan, what do we know about the origin of the SARSCOV2 virus?We were presented at the outset with two competing theories

more info


05/01/2024
The 'Biden Bump' That Didn't Last Long
Ever since Joe Biden's State of the Union address on March 7, Democrats have been hoping for a Biden surge.

more info


05/01/2024
If He Wins: Trump Lays Out Radical 2nd-Term Agenda
In exclusive interviews, the former president lays out a second-term agenda that would reshape America

more info


05/01/2024
Liberals Intent on Making Noncitizen Voting a Reality
I believe American citizens should decide American elections. A majority of voters on both sides of the aisle agree. Unfortunately, a small cohort of liberal activists is intent on making noncitizen voting a reality.

more info


05/01/2024
Far-Right Plans To Use Civil Rights Law To Disrupt 2024 Election
Experts describe the plan as a legal long shot, but say it could sow doubts about the integrity of a rematch between President Biden and former President Trump.

more info



Custom Search

More Politics Articles:

Related Articles

5 Financial Pressure Points To Evaluate During COVID Times


Financial pressure is a part of life for most people, and now the COVID-19 pandemic has brought new financial pressure points or exacerbated existing ones for many individuals and families.

Why Are People Complaining About Innovative COVID Treatments?


Gilead Sciences just announced it will charge $3,120 for a full course of Remdesivir, the first new FDA-approved treatment for COVID-19. Some knee-jerk members of Congress like Lloyd Doggett (D-Tex.) immediately condemned that price tag as "outrageous." The Institute for Clinical and Economic Review, a left-leaning nonprofit that releases its own recommendations of "fair" drug prices, claimed that Gilead could afford to price Remdesivir as low as $10 per course of treatment -- the cost of the raw ingredients used to make the drug.

Proposed Healthcare Reforms Will Not Help the Latinx Community


Joe Biden is officially the Democratic presidential nominee, all thanks to his moderate reputation.

Trade Enforcement Can Accelerate America's Economic Recovery


The stock market has largely rebounded from COVID-19 and American retail sales are improving steadily. Even more encouraging is that the U.S. unemployment rate fell for the fifth consecutive month in September. Each of these gains are sure signs that the Trump administration's economic response to the coronavirus crisis is working.

Drug Price Controls: Right Objective, Wrong Solution


This month, President Trump signed an executive order to reduce Medicare spending on prescription drugs. For each medication, Medicare will pay no more than the lowest price available in other developed countries.

Keep Thanksgiving, Family and Friends Alive


Joe Biden or Donald Trump will never visit me in my home, stand beside me at the funeral home or dance at my wedding. I will not be receiving any calls from either of them to pray for me during sickness or to check on how my children are doing. I probably will never sit in a room with them to visit, laugh and tell funny stories or just to hang out over a cup of coffee. I do not personally know either one. I welcome the opportunity to visit with either of them, but doubt it will happen.

The "E" Stands for “Excellence:” Remembering Walter E. Williams


Walter E. Williams, prolific author, piercing cultural commentator, old school economist (that’s a good thing), devoted husband, loving father, and long-time friend of Grove City College has passed from this world.

How Congress Can Really Fix Surprise Billing


House and Senate leaders recently agreed on legislation to end surprise medical bills as part of a big coronavirus relief package. President Trump signed it into law at the end of December.

A Federal Rule Will Reverse Strides in Cancer Treatment


"You've got cancer." That's one of the scariest sentences in the English language.

Biden Must Restore Seniors' Access to Essential Medicines


On January 19, Medicare officials announced a new payment model that could wreak havoc on the chronically ill.

Violence In America, Don't Be Surprised


The most recent attack at the United States Capitol will most likely insure a permanent fence and additional security. The attack which resulted in the loss of life for a long serving Capitol police officer and the attacker is another senseless violent act.

Protecting the Innovation that Protects Global Health


The most far-reaching healthcare policy decision of 2021 won't be made in Congress or the White House. It will be made at the World Trade Organization, which is considering a petition to waive all patent rights on Covid-19 vaccines.

Don't Repeat Europe's Vaccine Catastrophe


For many Americans, the calamitously slow vaccine roll-out in countries like Germany, France, and Italy comes as a surprise. After all, in the early days of the pandemic, Europe's response to the crisis seemed highly competent, especially compared to the United States.

A Full Plate for the New U.S. Trade Czar


The newly confirmed U.S. trade representative, Katherine Tai, is about as qualified as a person can be for the job. Which is a good thing, because she already faces a series of challenges.

Don't Let the US Import Europe's Failed Cancer Policies


With a majority in both the House and Senate and control of the Oval Office, Democratic leaders are excited about the prospect of making significant changes. One good example of this is the House Democrats' "Lower Drug Costs Now Act."